solli Sessions Live: Conversations from Fierce Pharma Week 2026

At Fierce Pharma Week 2026 in Philadelphia, solli took solli Sessions Live on the road, sitting down with leaders from across pharma, media, agencies and the wider healthcare ecosystem for a series of conversations recorded live from the event.

Hosted by Andrea Park, the interviews explore the issues at the centre of healthcare marketing today, from AI and the changing media landscape to HCP and patient engagement, storytelling, data and the evolving relationship between technology and human expertise.

Kevin Donahoe of Novo Nordisk explores how AI is changing pharma marketing, the evolving GLP-1 landscape and the opportunity to shift healthcare from “sick care” toward prevention, wellness and keeping people healthier for longer.

Quentin O’Brien-Romero of argenx explores what pharma can learn from rare disease marketing, from putting patients at the centre to bringing greater empathy and authenticity into HCP and patient engagement.

Greg Vennemann of Sumitomo Pharma America explores how AI is changing pharma marketing, why human connection remains essential and the opportunity to combine new technology with a return to marketing fundamentals.

Nadia Khatri of Ochre Signal Advisory explores how AI is reshaping pharma marketing and why human judgement, creativity and authenticity remain essential as the industry moves from task-based work toward more strategic decision-making.

Jeffrey Erb of Avalere Health explores how AI is transforming healthcare media, while highlighting the importance of human expertise, authentic storytelling and bringing patients and HCPs into the conversation.

Patient advocate Kristin Smedley explores the power of storytelling, community and lived experience, and why understanding the people behind healthcare can change perspectives, behaviours and, ultimately, outcomes.